Individual RF classes and subclasses can now be measured by solid phase assays. [7] [8] [9] It has been reported that increased IgA RF is more specific for RA than are increases in other RF classes, and IgA RF has also been claimed to be an indicator of poor prognosis.6 1 1 Thus IgA RF has been associated with early development of bone erosions'2-14 and with extra-articular manifestations, especially from secretory glands and mucous membranes. '5 16 To our knowledge, measurement of IgA subclasses in RA patients has been reported previously only by Otten et al,9 but their clinical significance was not evaluated.
We report the measurement of IgAl and IgA2 in a group of RA patients with and without extra-articular manifestations, patients with other rheumatic diseases, and in a group of symptom free individuals with increased total IgA RF.
Patients and methods

PATIENTS AND SAMPLES
We tested 219 serum samples for total IgA RF and both IgA RF subclasses. The samples were taken from three groups of patients: 58 RA patients attending the University Hospital outpatient clinic; 31 patients with other rheumatic diseases, including 22 with systemic lupus erythematosus, three with mixed connective tissue disease, two with juvenile rheumatoid arthritis, three with psoriatic arthritis, and one with Reiter's disease; 30 non-rheumatic individuals with increased total IgA RF. As this was a hospital based study, the RA patients tended to have severe disease. Samples from 100 randomly selected healthy individuals, aged 31 to 50, were used as controls.
The non-rheumatic individuals with increased concentrations of IgA RF had previously participated in a population based study on the significance of increased RF. 6 When the blood samples were collected, all participants answered a structured questionnaire about past and present rheumatic symptoms and diseases known to be associated with increased RF. Furthermore, they were assessed clinically and radiographs taken of their hands for determination of bone erosions. . The local standard was found to contain 3-75 times more of total IgA RF than the International Standard and was therefore given an arbitrary value of 375 units (AU/ml). Similarly, the local standard was given a value V of 375 AU/ml for both IgA RF subclasses.
-RF values above the 95% cut off level for 100 randomly selected controls were considered to be increased. Thus the upper limit of normal was 25 AU/ml for total IgA RF activity, 11 AU/ml for IgAl RF, and 23 AU/ml for IgA2 RF.
MEASUREMENT OF IgM RF IgM RF was measured by ELISA as previously described for IgA RF, except that mouse monoclonal anti-human IgM antibodies (Sigma, clone MB-ll) were used for detection of the solid phase bound RF. ' In addition, a significant positive correlation was noted between total IgA RF and both subclasses in patients with RA, while in the non-rheumatic individuals there was a positive correlation only between IgA RF and IgAl RF (table 4) .
Discussion
Although increased RF, as measured by conventional agglutination tests, is found in the majority of RA patients, it is also frequently found in patients with other rheumatic and non-rheumatic diseases. Agglutination tests mainly detect IgM RF and do not discriminate between patients with isolated increases in IgM RF and those with increases in both IgM RF and IgA RF. We have previously demonstrated that a concomitant increase in concentrations of IgM RF and IgA RF is much more specific for RA than increase in IgM RF or IgG RF alone. 18 This study indicates that increased IgA2 RF is markedly more common among RA patients than among patients with other rheumatic diseases, or symptom free individuals with increased total IgA RF. Furthermore, increased IgA2 RF seems to be more specific for RA than increased IgM RF (table 1) .
Otten et al9 reported a prevalence of increased IgAl RF in RA patients similar to the one we observed in this study (73% v 64%). However, they detected increased IgA2 RF concentrations in only 36% of their patients, compared with 60% of the RA patients in our study. This cannot be explained by different criteria used for defining the upper limit of normal, as a 95% cut off was used in both studies. No clinical details are presented in the report by Otten et al and it is therefore possible that their patients had less severe disease; however, 45% of our patients who had no evidence of extra-articular manifestations had increased IgA2 RF. A more likely explanation for the discrepancy may be that Otten's group used human IgG as antigen in their ELISA system, while we used rabbit IgG. It has been claimed that a stronger association has been found between increased IgA RF and bone erosions when rabbit IgG, rather than human IgG, has been used as antigen.'9 The pathophysiological significance of this phenomenon is not known, but it is conceivable that IgG molecules in individuals susceptible to RA share epitope(s) with rabbit IgG. It has indeed been shown that RF reacts more strongly with IgG from RA patients than with IgG from healthy subjects. 20 Otten et al did not analyse the relationship between IgA RF subclasses and disease manifestations in RA.9 Our findings that RA patients with extra-articular manifestations had greater concentrations of both IgA RF subclasses than patients without such manifestations are consistent with several previous studies, 1516 21 22 but also show that there is no real difference between the subclasses in this respect.
It has been reported that increase in RF concentration often precedes the clinical onset of RA by months or even years, and this may be particularly true for increases in IgA RF. 23 24 Thus it is possible that healthy individuals with increases in both IgA RF subclasses are at greater risk of later developing RA than those individuals who have increases in only the IgAl RF subclass. It is intended to follow the IgA RF positive non-rheumatic individuals presented in this study in order to evaluate this possibility.
This study has indicated that measurement of IgA RF subclasses may be diagnostically useful, but larger prospective studies are required to elucidate fully the prognostic and pathogenic significance of increased IgAl and IgA2 RF.
subclasses. 
Clinical implications of IgA rheumatoid factor
